This semester, the RPI-Mt. Sinai Center for Engineering and Precision Medicine (CEPM) welcomed the inaugural cohort of students in the center’s Ph.D. program in health sciences engineering jointly offered by RPI and Icahn School of Medicine at Mount Sinai.   

RPI professor and freshwater ecology expert Kevin Rose, Ph.D., in collaboration with other researchers from Rensselaer Polytechnic Institute (RPI), the Lake George Association (LGA), and Paul Smith’s College, conducted the first ever long-term study on the environmental effects of the aquatic herbicide florpyrauxifen-benzyl (FPB), also known as ProcellaCOR.

The Multi-Organ Approach to Address Diseases Following Estrogen Loss (MODEL) program aims to map the entire biological landscape of menopause

A discovery with major implications for cancer treatment has been made by a team of researchers from Rensselaer Polytechnic Institute (RPI), the University of Nebraska Medical Center (UNMC), University of Binghamton, and SUNY College of Environmental Science and Forestry.

Rensselaer Polytechnic Institute’s Georges Belfort, Ph.D., and Steven Cramer, Ph.D., both Institute Professors of Chemical and Biological Engineering, have won the 2025 Bernard M. Gordon Prize for Innovation in Engineering and Technology Education given by the National Academy of Engineering. 

Biotechnology researchers at Rensselaer Polytechnic Institute (RPI) are working to further improve mRNA therapeutics, with the aim of reducing manufacturing costs and enabling additional therapeutic uses for mRNA technology.

Bacteroides are essential bacteria in the human gut, playing a crucial role in our overall health. These microorganisms offer numerous benefits to their hosts, contributing to digestion and immune function. In their quest for survival, Bacteroides species are involved in fierce competition, employing mechanisms to interact and assert dominance. Certain Bacteroides species have developed ways to inject toxins into rival cells, showcasing their adaptability.

Rensselaer Polytechnic Institute (RPI) and the Icahn School of Medicine at Mount Sinai will offer a joint Ph.D. program in health sciences engineering beginning in the fall semester of 2025. RPI is a world-renowned technological research university known for its engineering, technology, and science programs. Icahn Mount Sinai is the academic arm of the Mount Sinai Health System, which includes eight hospitals and a vast network of ambulatory practices throughout the greater New York City region. The Ph.D.